Bone marrow injection into skull shows promise for major stroke
NCT ID NCT07203521
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study tests a new drug called RK-4 for people who have had a severe stroke and cannot receive standard clot-removal treatment. The drug is injected directly into the bone marrow of the skull for three days. Researchers want to see if it helps patients recover better and is safe. About 194 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSCRANIAL BONE MARROW INJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.